Heath Lukatch

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Vaxcyte Inc., 3 years.

Vaxcyte Inc. Director
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 6, 2024 Vaxcyte Inc. Grant or award +1,550 โ€” โ€”
Jan 31, 2024 Vaxcyte Inc. Option exercise +5,000 $16.00 $80,000
Jan 31, 2024 Vaxcyte Inc. Open-market sale โˆ’5,000 $71.50 $357,500
Jan 29, 2024 Vaxcyte Inc. Option exercise +4,000 $16.00 $64,000
Jan 29, 2024 Vaxcyte Inc. Open-market sale โˆ’4,000 $67.50 $270,000
Jan 2, 2024 Vaxcyte Inc. Option exercise +13,000 $16.00 $208,000
Jan 2, 2024 Vaxcyte Inc. Open-market sale โˆ’1,101 $62.85 $69,198
Jan 2, 2024 Vaxcyte Inc. Open-market sale โˆ’7,444 $63.55 $473,066
Jan 2, 2024 Vaxcyte Inc. Open-market sale โˆ’4,164 $64.28 $267,662
Jan 2, 2024 Vaxcyte Inc. Open-market sale โˆ’291 $65.19 $18,970
Jun 13, 2023 Vaxcyte Inc. Grant or award +2,500 โ€” โ€”
Jan 10, 2023 Vaxcyte Inc. Option exercise +315 $16.00 $5,040
Jan 10, 2023 Vaxcyte Inc. Open-market sale โˆ’233 $46.04 $10,727
Jan 10, 2023 Vaxcyte Inc. Open-market sale โˆ’82 $46.33 $3,799

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.